Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity

Dirk M. Zajonc(Scripps Research Institute), Igor Maricic(Torrey Pines Institute For Molecular Studies), Douglass Wu(Scripps Research Institute), Ramesh Halder(Torrey Pines Institute For Molecular Studies), Keshab Chandra Roy(Torrey Pines Institute For Molecular Studies), Chi‐Huey Wong(Scripps Research Institute), Vipin Kumar(Torrey Pines Institute For Molecular Studies), Ian A. Wilson(Scripps Research Institute)
The Journal of Experimental Medicine
November 28, 2005
Cited by 188Open Access
Full Text

Abstract

Sulfatide derived from the myelin stimulates a distinct population of CD1d-restricted natural killer T (NKT) cells. Cis-tetracosenoyl sulfatide is one of the immunodominant species in myelin as identified by proliferation, cytokine secretion, and CD1d tetramer staining. The crystal structure of mouse CD1d in complex with cis-tetracosenoyl sulfatide at 1.9 A resolution reveals that the longer cis-tetracosenoyl fatty acid chain fully occupies the A' pocket of the CD1d binding groove, whereas the sphingosine chain fills up the F' pocket. A precise hydrogen bond network in the center of the binding groove orients and positions the ceramide backbone for insertion of the lipid tails in their respective pockets. The 3'-sulfated galactose headgroup is highly exposed for presentation to the T cell receptor and projects up and away from the binding pocket due to its beta linkage, compared with the more intimate binding of the alpha-glactosyl ceramide headgroup to CD1d. These structure and binding data on sulfatide presentation by CD1d have important implications for the design of therapeutics that target T cells reactive for myelin glycolipids in autoimmune diseases of the central nervous system.


Related Papers

No related papers found

Powered by citation graph analysis